Fairfax Completes US$1 Billion Senior Notes Offering

Written by Customer Service on March 22, 2024. Posted in Public Companies.

TORONTO, March 22, 2024 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) has completed its previously announced offering of US$1,000,000,000 in aggregate principal amount of 6.350% senior notes due 2054 (the “Notes”). In connection with the closing of the offering, Fairfax entered into a customary registration rights agreement. Fairfax intends to use the net proceeds of this offering for general corporate purposes. The offering was made solely by means of a private placement either to qualified institutional buyers pursuant to Rule 144A under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or to certain non-U.S. persons in offshore transactions pursuant to Regulation S under the Securities Act. The Notes have not been registered under the Securities Act and the Notes may...

IBEX Reports Results for the Second Quarter and Six Months Ended January 31, 2024

Written by Customer Service on March 22, 2024. Posted in Earnings Releases And Operating Results.

MONTRÉAL, March 22, 2024 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the second quarter and the six months ended January 31, 2024. “We were pleased to see revenues continue to increase as Q2 revenues were up 12% versus a year ago and the six-month revenues up 15%. The increase in revenues can mainly be attributed to the strong performance of customers in the hemostasis market” said Paul Baehr, President & CEO. Net earnings were down due to the expenses associated with the proposed acquisition of IBEX by BBI Solutions OEM Limited (“BBI”). Note: All figures are in Canadian dollars unless otherwise stated. The Company’s audited consolidated financial statements for the year ended July 31, 2023, and the accompanying notes and the related management’s...

Tandy Leather Factory Reports Fourth Quarter and Full Year 2023 Results

Written by Customer Service on March 22, 2024. Posted in Earnings Releases And Operating Results.

FORT WORTH, Texas, March 22, 2024 (GLOBE NEWSWIRE) — Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company’s financial results for the fourth fiscal quarter and full year 2023. Highlights from 2023: Revenues were $76.2 million, down 5.1% from 2022 Generated operating income of $4.4 million Net income of $3.8 million, up from $1.2 million in 2022 Gross margins of 59.3%, up from 57.9% in 2022 Operating expenses $40.8 million, down 9.7% from 2022 Adjusted EBITDA* of $6.5 million Ended year with $12.2 million of cash and cash equivalents The Company’s full year sales were $76.2 million in 2023, down from $80.3 million in 2022. Operating expenses decreased to $40.8 million from $45.1 million in 2022 and decreased as a percentage of sales to 53.5% from 56.2% in 2022. 2023 full year gross profit was $45.2 million, or...

Scorpio Tankers Inc. Announces Availability of 2023 Annual Report on Form 20-F

Written by Customer Service on March 22, 2024. Posted in Public Companies.

MONACO, March 22, 2024 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE: STNG) (“Scorpio Tankers” or the “Company”) announced today that its Annual Report on Form 20-F for the year ended December 31, 2023 has been filed with the Securities and Exchange Commission and can be accessed on the Company’s website www.scorpiotankers.com in the Investors section under Reports and Presentations. Shareholders may also request a hard copy of the Annual Report, which includes the Company’s complete 2023 audited financial statements, free of charge, by contacting the Company at: Scorpio Tankers Inc.Attn: Investor Relations150 E 58th StreetNew York, NY 10155Tel: +1-212-542-1616E-mail: investor.relations@scorpiotankers.com Reports and other information regarding the Company are also available without charge at a website maintained by the U.S. Securities...

Nutra Pharma Corp. Reaches Settlement with SEC

Written by Customer Service on March 22, 2024. Posted in Public Companies.

Nutra Pharma Corp. has reached a bifurcated settlement with the SEC along with its CEO and a Consultant to the company CORAL SPRINGS, Fla., March 22, 2024 (GLOBE NEWSWIRE) — Nutra Pharma Corporation (OTC: NPHC), (“Nutra Pharma” or the “Company”) reached a settlement with the U.S. Securities and Exchange Commission (“SEC”) earlier this week. On March 19, 2024, the United States District Court for the Eastern District of New York in SEC v. Nutra Pharma Corporation, Erik Deitsch a/k/a Rik Deitsch, and Sean Peter McManus, Case No. 1:18-cv-05459-JS (E.D.N.Y.), approved bifurcated settlements in the form of consent judgments (the “Consent Judgments”) entered by the Court, wherein the Defendants, without admitting or denying the allegations of the Complaint except as to personal and subject matter jurisdiction, resolved all liability...

Sysco Honors Louisville Fire Department for Heroic Bridge Rescue by Filling Firehouse Pantries, Donating $20,000 to Annual Award Banquet

Written by Customer Service on March 22, 2024. Posted in Public Companies.

Sysco President and CEO Kevin Hourican announced the generous donation at a news conference with Louisville Mayor Craig Greenberg and Louisville Fire Chief Brian O’Neill LOUISVILLE, Ky., March 22, 2024 (GLOBE NEWSWIRE) — Today, Sysco President and CEO Kevin Hourican announced Sysco Corporation (NYSE:SYY), the leading global foodservice distribution company, had filled two Louisville firehouse pantries and donated $20,000 toward their annual award banquet in a gesture of thanks for their heroic bridge rescue of a Sysco delivery partner.   Louisville Mayor Craig Greenberg and Louisville Fire Chief Brian O’Neill joined Hourican to honor the firefighters and first responders who on March 1 rescued a Sysco driver whose truck was hanging precariously over the Ohio River from the Clark Memorial Bridge. Firefighter Bryce Carden repelled...

DIAGNOS Announces Closing of Second and Final Tranche of Private Placement

Written by Customer Service on March 22, 2024. Posted in Public Companies.

BROSSARD, Quebec, March 22, 2024 (GLOBE NEWSWIRE) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence (AI) technologies, announces the closing of a second and final tranche of 650,000 units (each a “Unit”) issued at a price of $0.28 per Unit, for gross proceeds of $182,000, of a non-brokered private placement initially announced on February 27, 2024 (“Private Placement”). Combined with the first closing announced on February 27, 2024, the aggregate number of Units is 2,064,286 and the aggregate gross proceeds amount to $578,000.08. Each Unit consists of: – One (1) common share (“Share”), and – One (1) common share warrant (“Warrant”). As part of the closing of the second and final tranche...

Alvotech Announces Increase in Number of Own Shares

Written by Customer Service on March 22, 2024. Posted in Public Companies.

Alvotech (NASDAQ: ALVO) (the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, has increased the Company´s share capital by an amount of one hundred and thirty thousand (USD 130,000) by issuing thirteen million (13,000,000) ordinary shares. The Company’s subsidiary, Alvotech Manco ehf. (the “subsidiary”), has subscribed to all of the newly issued shares for a price of USD 15.98 per share. The shares held by the subsidiary are treated as treasury shares without voting rights or dividend entitlement. Following the above-mentioned transactions, the subsidiary will hold 23.160.596 shares in the Company, or around 7.7% of issued shares, and the number of issued shares has increased from 289,727,462 to 302,727,462 shares as a result thereof. On 26 February 2024,...

Alvotech Announces Increase in Number of Own Shares

Written by Customer Service on March 22, 2024. Posted in Public Companies.

REYKJAVIK, Iceland, March 22, 2024 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO) (the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, has increased the Company´s share capital by an amount of one hundred and thirty thousand (USD 130,000) by issuing thirteen million (13,000,000) ordinary shares. The Company’s subsidiary, Alvotech Manco ehf. (the “subsidiary”), has subscribed to all of the newly issued shares for a price of USD 15.98 per share. The shares held by the subsidiary are treated as treasury shares without voting rights or dividend entitlement. Following the above-mentioned transactions, the subsidiary will hold 23,160,596 shares in the Company, or around 7.7% of issued shares, and the number of issued shares has increased from 289,727,462...

Bunker Hill Announces Election to Issue Shares in Satisfaction of Debenture Interest Payment Obligations

Written by Customer Service on March 22, 2024. Posted in Public Companies.

TORONTO, March 22, 2024 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V: BNKR; OTCQB: BHLL) announces that it has elected to issue an aggregate of 6,398,439 shares of common stock of the Company (the “Interest Shares”) to certain holders of 7.5% convertible debentures (the “Series 1 Convertible Debentures”) and 10.5% convertible debentures (the “Series 2 Convertible Debentures” and, together with the Series 1 Convertible Debentures, the “Convertible Debentures”) in full satisfaction of the interest payable thereunder as of March 31, 2024 in the aggregate amount of USD$511,875.00 (the “Interest Payment”). The Convertible Debentures mature on March 31, 2026. In accordance with the terms of the Convertible Debentures, the Company will issue the Interest Shares at a price of USD$0.08 per Interest...

Day: March 22, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice